At a glance
- Originator University of Pennsylvania
- Developer GE Healthcare
- Class Organotechnetium compounds; Radiopharmaceutical diagnostics; Tropanes
- Mechanism of Action Single-photon emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 11 Sep 2006 No development reported - Preclinical investigation for diagnosis of Parkinson's disease in USA (IV)
- 16 Apr 2004 Amersham has merged with GE Medical Systems to form GE Healthcare
- 02 Oct 2002 Preclinical investigation for diagnosis of Parkinson's disease in USA (IV)